Synthetic compound slows down aging of mice with mutating

February 20, 2017, Lomonosov Moscow State University
A genetically-modified mouse participated in the experiment. Credit: The A.N. Belozersky Institute Of Physico-Chemical Biology

A group of Russian and Swedish scientists just published a breakthrough paper, reporting results of a joint study by Lomonosov Moscow State University and Stockholm university. The article was published in the U.S. journal Aging.

The major goal of the study was to investigate the role of intracellular power stations—mitochondria—in the aging process. Importantly, scientists made an attempt to slow down aging using a novel compound: artificial antioxidant SkQ1 precisely targeted to mitochondria. This compound was developed at Moscow State University by biologist Professor Vladimir Skulachev.

Experiments involved a special strain of genetically modified mice created and characterized in Sweden. A single mutation was introduced into genome of these mice resulting in substantially accelerated mutagenesis in mitochondria. This leads to accelerated aging and early death of the mutant mice. They live less than one year, while normal mice live more than two years. The mutation promotes development of many age-related defects and diseases, indicating that the major defect of these mice is indeed aging.

Starting from the age of 100 days, one group of was treated with small doses of SkQ1 (approx. 12 micrograms) added to their drinking water. Per the researchers' hypothesis, the compound would protect the animals' cells from the toxic byproducts of mitochondria—free radicals (). Another group of animals served as a , receiving pure water.

Differences between the two groups became obvious starting from the age 200 to 250 days. Animals in the control group aged rapidly as expected. They lost weight, their body temperature decreased, they exhibited severe curvature of the spin eas a result of osteoporosis and developed alopecia. Their skin became thinner, and in the case of females, the estrus cycle was impaired. Finally, their mobility and oxygen consumption decreased. The development of all these typical traits of aging was dramatically decelerated in the group treated with SkQ1. Some of the aging traits did not appear in that group at all.

Professor Vladimir Skulachev, the designer of SkQ1 molecule and co-author of this study, says, "This work is quite valuable from both theoretical and practical points of view. First, it clearly demonstrates the key role of mitochondrially produced reactive oxygen species in the process of aging of mammals. At the same time, our study opens the way to the treatment of aging with mitochondrially targeted antioxidants."

Prof. Skulachev's project is now developing a set of pharmaceuticals based on SkQ1 molecule. The first drug—Visomitin eye drops—is already approved and marketed in Russia. It also passed phase 2 clinical trials in the U.S. The next pharmaceutical product in project's pipeline is an oral form of SkQ1 similar to the one used in the experiments. It is now in the process of in Russia. If it achieves positive results, an "anti-aging" drug can be approved for systemic indications in two to three years.

Explore further: Scientists determine the mechanism of a drug that protects cell mitochondria from damage by aggressive oxygen

More information: Irina G. Shabalina et al, Improved health-span and lifespan in mtDNA mutator mice treated with the mitochondrially targeted antioxidant SkQ1, Aging (2017). DOI: 10.18632/aging.101174

Related Stories

Scientists determine the mechanism of a drug that protects cell mitochondria from damage by aggressive oxygen

May 12, 2016
An international team of scientists led by researchers from the Lomonosov Moscow State University clarified the molecular mechanism of a drug created in Russia and designed to prevent the damaging of cell mitochondria by ...

New protein provides critical link between aging and age-dependent disease

November 15, 2016
The discovery of a novel protein that links aging and age-dependent retinal diseases could lead to potential new treatments for conditions that cause sight loss in later life.

Team identifies mechanisms of inflammation-induced animal aging

January 17, 2017
DGIST's research team has experimentally proved the hypothesis that the accumulated chronic inflammation results in the aging of animals.

Does interleukin-10 reduce age-related insulin resistance?

November 16, 2016
New research published online in The FASEB Journal suggests that the anti-inflammatory molecule IL-10 may do more than just reduce inflammation. In the report, scientists use mice to show that the molecule may also help reduce ...

Substance with the potential to postpone aging

October 14, 2016
The coenzyme NAD+ plays a main role in aging processes. In mice and roundworm adding the substance can both extend life and postpone the onset of aging processes. New research conducted at the Center for Healthy Aging and ...

Surprising results casts new light on the free radical theory of aging

August 3, 2015
When scientists in the Campisi lab at the Buck Institute bred mice that produced excess free radicals that damaged the mitochondria in their skin, they expected to see accelerated aging across the mouse lifespan - additional ...

Recommended for you

Stem cell researchers develop promising technique to generate new muscle cells in lab

December 12, 2018
To help patients with muscle disorders, scientists at The University of Texas Health Science Center at Houston (UTHealth) have engineered a new stem cell line to study the conversion of stem cells into muscle. Findings appeared ...

Gut hormone increases response to food

December 12, 2018
The holiday season is a hard one for anyone watching their weight. The sights and smells of food are hard to resist. One factor in this hunger response is a hormone found in the stomach that makes us more vulnerable to tasty ...

New insight into stem cell behaviour highlights therapeutic target for cancer treatment

December 12, 2018
Research led by the University of Plymouth and Technische Universität Dresden has identified a new therapeutic target for cancer treatment and tissue regeneration – a protein called Prominin-1.

New mouse model may speed identification of promising muscular dystrophy therapies

December 12, 2018
A Massachusetts General Hospital (MGH) research team has created a new mouse model of a common form of muscular dystrophy with the potential of rapidly distinguishing promising therapeutic drugs from those unlikely to be ...

Study examines disruption of circadian rhythm as risk factor for diseases

December 11, 2018
USC scientists report that a novel time-keeping mechanism within liver cells that helps sustain key organ tasks can contribute to diseases when its natural rhythm is disrupted.

New light-based technology reveals how cells communicate in human disease

December 11, 2018
Scientists at the University of York have developed a new technique that uses light to understand how cells communicate in human disease.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.